IPOs on Nasdaq, backed by Eli Lilly, focusing on Treg science for autoimmune disorders. Pipeline includes TRB-061 and a CD30 agonist for IBD.
PhRMA says FDA will get money it can spend only on hiring and keeping staff, to restore reviewer levels after the HHS layoffs ...
WHO releases preeclampsia roadmap; Comanche, DiaMedica, Avilar & ProFound developing treatments; Eli Lilly exploring the ...
Biohaven licenses pan-IgG degraders to Ono for $80M; UK pulls Ixchiq; ADC raises $86.6M; BMS Zenbexus Phase 3 win; Pfizer ...
Grindr acquires Freddie's parent for $250M to expand into HIV prevention (PrEP). The company will combine that with ED drugs and GLP-1s under new Grindr Health brand.
Petrelintide reduced patients’ average body weight by up to 9.2%, compared to 2.0% among those who received placebo.
General Medicine raises a $120M Series B led by a16z, betting its 2,900-product catalog can serve AI shopping agents as well as people.
Roche partners with Hangzhou-based Defand Therapeutics in a ~$1B deal, under $10M upfront, to develop molecular glue ...
PhRMA sued CMS over GLOBE, the Trump admin's Medicare Part B demo tying drug prices to overseas rates, calling it unlawful.
Ultragenyx sells a rare pediatric disease PRV for $210M, one of 2026's priciest voucher deals, and plans to monetize a second ...
The court ruled that Merck infringed one of Halozyme's patents and granted an injunction that bars Merck from marketing subcutaneous Keytruda in Belgium, Denmark, France, Ireland, Italy, Sweden, ...
Chan Zuckerberg Biohub launches $1.8B Virtual Biology Initiative with Meta, Google DeepMind, Isomorphic Labs, DOE, and NIH to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results